CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cordlife Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cordlife Group Ltd
1 Yishun Industrial Street 1
A'Posh Bizhub, # 06 01 09
Phone: +65 62380808p:+65 62380808 768160  Singapore Ticker: P8AP8A

Business Summary
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202112/31/2020Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Acting Independent Chairman of the Board Choon HouHo 43 10/1/2020 6/16/2011
Group Chief Executive Officer, Executive Director Poh LanTan 57 2/28/2019 4/12/2016
Group Chief Financial Officer ChooBoon Yong 48 2/1/2017 2/1/2017
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
StemLife Berhad B-7-15 KUALA LUMPUR Malaysia

Business Names
Business Name
Cordlife Stem Cell Technology Limited
CS Cell Technologies Pte. Ltd
Healthbaby Biotech (Hong Kong) Co. Limited
P.T. Cordlife Indonesia
P8A
StemLife Berhad

General Information
Number of Employees: 111 (As of 6/30/2011)
Outstanding Shares: 255,301,444 (As of 6/30/2021)
Shareholders: 1,867
Stock Exchange: SIN
Fax Number: +65 62381108


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 19, 2022